GO:0016866 intramolecular transferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016866 intramolecular transferase activity describes enzymes that move a functional group from one position to another within the same molecule, a reaction class historically called mutase activity.
• These enzymes are central to metabolic rearrangements, cofactor biosynthesis, and the maturation of RNA and proteins, often using radical or S-adenosylmethionine-dependent chemistry.
• Pseudouridylate synthases (PUS enzymes) are paradigmatic intramolecular transferases that isomerize uridine to pseudouridine in RNA and are implicated in cancer progression.
• tRNA modification complexes rely on intramolecular transferase steps to introduce wobble-position modifications that expand codon recognition.
• Dysregulation of intramolecular transferases can contribute to colon cancer, ribosomopathies, and neurological disorders, making them candidate therapeutic targets.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of intramolecular transferase genes in disease and development.
Description
Intramolecular transferase activity (GO:0016866) is a molecular function defined as the catalysis of the transfer of a functional group from one position to another within a single molecule. This class of enzymes, often referred to as mutases, is essential for rearranging molecular architectures without changing the overall composition of the substrate. They participate in diverse pathways, including central carbon metabolism, amino acid biosynthesis, and the post-transcriptional modification of RNA. The importance of intramolecular transferases extends to human health, as mutations or dysregulation in these enzymes have been linked to cancer, metabolic disorders, and developmental defects. For researchers, understanding GO:0016866 provides a framework to study enzyme mechanism, substrate specificity, and the role of these catalysts in cellular physiology and disease. The integration of structural biology, enzymology, and CRISPR-based genetics has accelerated the functional annotation of intramolecular transferases, revealing both canonical and unexpected roles in cell proliferation and signaling.
intramolecular transferase activity At A Glance
| GO ID | GO:0016866 |
|---|---|
| GO term | intramolecular transferase activity |
| Ontology | molecular_function |
| Synonym | mutase activity; intramolecular transferase activity, transferring other groups |
| Major function | Catalysis of the transfer of a functional group from one position to another within a single molecule |
| Example enzymes | Pseudouridylate synthases, phosphoglucomutases, methylmalonyl-CoA mutases |
| Cofactors | S-adenosylmethionine, adenosylcobalamin, metal ions |
| Biological context | RNA modification, tRNA maturation, central metabolism, cofactor biosynthesis |
What Is GO:0016866?
In our own words, intramolecular transferase activity (GO:0016866) refers to the catalytic action of an enzyme that relocates a chemical group, such as a phosphate, methyl, or glycosyl moiety, from one site to another within the same molecule. This definition is based on the QuickGO entry, which specifies the transfer of a functional group from one position to another within a single molecule. The term is synonymous with mutase activity and encompasses enzymes that often employ radical or S-adenosylmethionine-dependent mechanisms to achieve this rearrangement.
Why Is intramolecular transferase activity Important in Cell Biology?
Intramolecular transferase activity is fundamental to cellular chemistry because it enables the rearrangement of molecular structures without the need for external group donors or acceptors. This is critical for the biosynthesis of essential cofactors, the modification of RNA and proteins, and the proper functioning of metabolic pathways. In humans, defects in intramolecular transferases can lead to disease; for instance, pseudouridylate synthase 7 (PUS7) promotes colon cancer proliferation and invasion through activation of PI3K/AKT/mTOR signaling. Moreover, the box H/ACA small ribonucleoproteins, which include pseudouridine synthases, are key players in ribosome biogenesis and are associated with ribosomopathies. Thus, studying GO:0016866 offers insights into both basic enzymology and translational opportunities for therapeutic intervention.
• Enables intramolecular rearrangements essential for metabolic pathways and cofactor biosynthesis.
• Pseudouridine synthases, a major class of intramolecular transferases, modify RNA and influence translation and stability.
• tRNA modification complexes depend on intramolecular transferase steps for codon recognition and translational fidelity.
• Dysregulation of intramolecular transferases is linked to cancer, as shown for PUS7 in colon cancer.
• Mutations in these enzymes can cause metabolic disorders and neurological phenotypes.
• They are targets for antibiotic and anticancer drug development due to their essential roles.
• Intramolecular transferases often use radical chemistry, expanding the mechanistic repertoire of enzymes.
• Understanding their regulation can reveal feedback mechanisms, such as intramolecular negative regulation in Jak3.
• CRISPR screens can identify novel intramolecular transferases involved in disease pathways.
• Their activity can be modulated by post-translational modifications and allosteric interactions.
Molecular Mechanism of intramolecular transferase activity
Substrate Recognition and Binding
In simple terms: The enzyme first grabs its target molecule and holds it in the right position.
Intramolecular transferases recognize specific substrates through a combination of shape and chemical complementarity. For example, pseudouridylate synthases bind to RNA hairpins and flip out the target uridine residue to access the catalytic site. The binding step often induces conformational changes that position the functional group for transfer. In tRNA modification complexes, the enzyme must discriminate among numerous tRNA species to modify only the correct position. This specificity is crucial for avoiding off-target modifications that could impair cellular function.
Catalytic Transfer and Rearrangement
In simple terms: The enzyme moves a chemical group from one spot to another within the same molecule.
The catalytic step involves the breakage and formation of chemical bonds within the substrate. Radical mechanisms are common, as seen in enzymes that use adenosylcobalamin or S-adenosylmethionine to generate reactive intermediates. For instance, pseudouridylate synthase isomerizes uridine to pseudouridine by cleaving the N-glycosidic bond and reattaching the base via a carbon-carbon bond. This rearrangement is energetically demanding and often requires cofactors or metal ions to stabilize transition states. The reaction is typically irreversible under physiological conditions, driving the pathway forward.
Cofactors and Cofactor Regeneration
In simple terms: Some of these enzymes need helper molecules to perform the transfer.
Many intramolecular transferases depend on cofactors such as S-adenosylmethionine (SAM) or adenosylcobalamin (vitamin B12) to initiate radical chemistry. SAM-dependent enzymes generate 5'-deoxyadenosyl radicals that abstract hydrogen atoms from the substrate, facilitating group migration. Adenosylcobalamin-dependent mutases, like methylmalonyl-CoA mutase, use the cofactor to form a transient radical that drives carbon skeleton rearrangement. After catalysis, the cofactor must be regenerated to its active form, often through redox reactions or conformational changes.
Regulation and Intramolecular Control
In simple terms: The enzyme's activity can be switched on or off by changes within the protein itself.
Intramolecular transferase activity can be regulated by post-translational modifications, allosteric effectors, or intramolecular interactions. A notable example is the intramolecular negative regulation of mouse Jak3 activity by tyrosine 820, where phosphorylation of this residue within the kinase domain suppresses activity. This illustrates how a single molecule can self-regulate its catalytic function. In RNA modification enzymes, substrate availability and the assembly of modification complexes control activity. Dysregulation of these control mechanisms can lead to disease, as seen in cancers where pseudouridylate synthases are overexpressed.
Key Genes Involved in GO:0016866 intramolecular transferase activity
The following genes encode enzymes with intramolecular transferase activity or are directly involved in its regulation and downstream effects, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PUS7 | Pseudouridylate synthase that isomerizes uridine to pseudouridine in RNA | Promotes colon cancer proliferation and invasion via PI3K/AKT/mTOR signaling |
| DAPK1 | Serine/threonine kinase involved in apoptosis; interacts with multiple proteins | Its interactome includes enzymes with transferase activity, linking to cell death pathways |
| JAK3 | Tyrosine kinase essential for immune cell signaling | Intramolecular negative regulation by tyrosine 820 modulates its activity |
| PUS1 | Pseudouridylate synthase that modifies tRNA and snRNA | Mutations cause mitochondrial myopathy and sideroblastic anemia |
| DKC1 | Dyskerin, a pseudouridylate synthase in box H/ACA RNPs | Defects cause dyskeratosis congenita and ribosomopathies |
| NOP10 | Accessory protein of box H/ACA RNPs | Required for pseudouridylation and ribosome biogenesis |
| GAR1 | Box H/ACA RNP component | Facilitates pseudouridylate synthase activity on rRNA |
| NHP2 | Box H/ACA RNP component | Stabilizes the RNP complex for RNA modification |
| MUT | Methylmalonyl-CoA mutase, an adenosylcobalamin-dependent intramolecular transferase | Defects cause methylmalonic acidemia |
| PGM1 | Phosphoglucomutase, catalyzes intramolecular phosphate transfer | Deficiency leads to glycogen storage disease |
| PUS3 | Pseudouridylate synthase specific for tRNA | Modifies tRNA to ensure translational fidelity |
| PUS4 | Pseudouridylate synthase in yeast and humans | Involved in tRNA and rRNA modification |
| TRUB1 | tRNA pseudouridine synthase | Modulates tRNA stability and function |
| PUS10 | Pseudouridylate synthase involved in miRNA processing | Links RNA modification to gene regulation |
| RPUSD1 | RNA pseudouridylate synthase domain containing 1 | Potential role in mitochondrial RNA modification |
| RPUSD2 | RNA pseudouridylate synthase domain containing 2 | Candidate for mitochondrial ribosome assembly |
| RPUSD3 | RNA pseudouridylate synthase domain containing 3 | Associated with mitochondrial function |
| RPUSD4 | RNA pseudouridylate synthase domain containing 4 | Implicated in mitochondrial RNA processing |
How Is intramolecular transferase activity Regulated?
Intramolecular transferase activity is regulated at multiple levels. At the protein level, post-translational modifications such as phosphorylation can directly modulate catalytic activity, as demonstrated by the intramolecular negative regulation of Jak3 by tyrosine 820. Allosteric interactions and substrate availability also control enzyme turnover. In RNA modification, the assembly of box H/ACA small ribonucleoproteins is essential for pseudouridylate synthase activity, and disruption of complex formation impairs modification. Additionally, the expression of genes encoding intramolecular transferases can be regulated transcriptionally, as seen in cancers where PUS7 is overexpressed and drives oncogenic signaling. Metabolic feedback and cofactor availability further influence activity, particularly for enzymes requiring S-adenosylmethionine or adenosylcobalamin.
intramolecular transferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PUS7 | Colon cancer; promotes proliferation and invasion via PI3K/AKT/mTOR | Knockout and overexpression in colon cancer cell lines; xenograft models |
| DKC1 | Dyskeratosis congenita; ribosomopathy | Patient-derived iPSCs with point mutations; zebrafish models |
| MUT | Methylmalonic acidemia | Knockout mouse models; patient fibroblasts |
| PGM1 | Glycogen storage disease | Knockout cell lines; enzymatic assays |
| JAK3 | Severe combined immunodeficiency; intramolecular regulation | Knock-in mice with Y820F mutation; T cell signaling assays |
Cancer
Dysregulation of intramolecular transferases contributes to cancer. Pseudouridylate synthase 7 (PUS7) promotes cell proliferation and invasion in colon cancer through activation of the PI3K/AKT/mTOR signaling pathway. High PUS7 expression correlates with poor prognosis, suggesting its potential as a therapeutic target. Other pseudouridine synthases may also play roles in tumorigenesis by modifying RNAs that control oncogene expression.
Ribosomopathies and Developmental Disorders
Mutations in genes encoding box H/ACA small ribonucleoprotein components, such as DKC1, NOP10, NHP2, and GAR1, cause dyskeratosis congenita and other ribosomopathies. These proteins are essential for pseudouridylation of rRNA, and their loss impairs ribosome biogenesis, leading to bone marrow failure and developmental defects. The intramolecular transferase activity of dyskerin is critical for maintaining stem cell function and telomere integrity.
Metabolic and Neurological Disorders
Defects in metabolic intramolecular transferases, such as methylmalonyl-CoA mutase (MUT) and phosphoglucomutase 1 (PGM1), cause methylmalonic acidemia and glycogen storage disease, respectively. These disorders highlight the importance of intramolecular group transfer in intermediary metabolism. Additionally, neurological phenotypes have been associated with impaired tRNA modification by pseudouridylate synthases, affecting translation in neurons.
From intramolecular transferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PUS7 reduce tumor growth? | CRISPR knockout of PUS7 in colon cancer cell lines and mouse xenografts |
| How does a point mutation in JAK3 affect kinase activity? | Knock-in of Y820F mutation in mouse models |
| What is the role of DKC1 pseudouridylation in ribosome biogenesis? | Knock-in of patient mutations in iPSCs; RNA modification profiling |
| Can overexpression of PUS7 drive oncogenic transformation? | Overexpression of PUS7 in normal colon epithelial cells |
| How does MUT deficiency alter metabolism? | Knockout of MUT in hepatocytes; metabolomics |
| What is the impact of tRNA pseudouridylation on translation? | Point mutations in PUS3 or PUS4 in yeast and human cells; Ribo-seq |
How to Study the intramolecular transferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Pseudo-seq | Transcriptome-wide pseudouridine sites | Mapping RNA modifications by PUS enzymes |
| Ribo-seq | Ribosome occupancy and translation efficiency | Assessing impact of tRNA modifications |
| Mass spectrometry | Enzyme kinetics and cofactor usage | Characterizing radical mechanisms |
| CRISPR knockout screens | Gene essentiality and fitness | Identifying oncogenic transferases |
| Phosphoproteomics | Post-translational modifications | Studying regulation of Jak3 |
| Affinity purification-MS | Protein-protein interactions | Mapping DAP-kinase interactome |
| Acid-urea gel electrophoresis | Pseudouridine levels in RNA | Validating PUS activity |
| Metabolomics | Metabolic flux and intermediate levels | Studying MUT and PGM1 deficiencies |
Enzymatic Assays for Intramolecular Transfer
Direct measurement of intramolecular transferase activity can be achieved using radiolabeled substrates or mass spectrometry to track the migration of functional groups. For pseudouridylate synthases, acid-urea gel electrophoresis or HPLC can separate pseudouridine from uridine. These assays are essential for validating enzyme kinetics and inhibitor screening.
RNA Modification Profiling
Next-generation sequencing-based methods such as Pseudo-seq, Ribo-seq, and tRNA-seq enable transcriptome-wide mapping of pseudouridine and other modifications introduced by intramolecular transferases. These techniques reveal substrate specificity and the impact of modifications on translation. They are particularly useful for studying PUS enzymes in cancer and development.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry can identify protein-protein interactions of intramolecular transferases, as demonstrated for the DAP-kinase interactome. This approach uncovers regulatory complexes and substrates. Phosphoproteomics can reveal post-translational modifications that regulate enzyme activity, such as Jak3 Y820 phosphorylation.
CRISPR Screens and Functional Genomics
Genome-wide CRISPR knockout screens can identify intramolecular transferases required for cell proliferation or drug resistance. For example, screens in colon cancer cells may highlight PUS7 as a fitness gene. Coupling screens with RNA modification profiling links genotype to phenotype.
How CRISPR Can Be Used to Study GO:0016866 intramolecular transferase activity
Knockout
CRISPR knockout of intramolecular transferase genes, such as PUS7, can abolish their catalytic activity and reveal loss-of-function phenotypes. In colon cancer cells, PUS7 knockout reduces proliferation and invasion, confirming its oncogenic role. Knockout models are also used to study metabolic enzymes like MUT, where loss leads to metabolite accumulation.
Point Mutation
Point mutations can dissect specific catalytic residues or regulatory sites. For example, mutating tyrosine 820 in Jak3 to phenylalanine (Y820F) prevents negative regulation, leading to hyperactive kinase. Such models are invaluable for understanding intramolecular control mechanisms. In pseudouridylate synthases, active-site mutations can separate catalytic activity from substrate binding.
Knock-in
Knock-in of disease-associated mutations in intramolecular transferase genes, such as DKC1 mutations found in dyskeratosis congenita, allows study of ribosomopathy mechanisms in isogenic cell lines. Knock-in of tagged versions (e.g., FLAG or GFP) enables localization and interaction studies.
Overexpression
Overexpression of intramolecular transferases like PUS7 can drive oncogenic transformation and activate signaling pathways such as PI3K/AKT/mTOR. Overexpression models are useful for identifying downstream effects and potential therapeutic vulnerabilities. They also help study enzymes that are normally expressed at low levels.
How EDITGENE Supports intramolecular transferase activity Research
Researchers studying intramolecular transferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as cancer cell proliferation or RNA modification. This requires precise genetic manipulation to avoid confounding effects. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for intramolecular transferase activity research.
Frequently Asked Questions About intramolecular transferase activity
What is intramolecular transferase activity?
Intramolecular transferase activity (GO:0016866) is the catalysis of the transfer of a functional group from one position to another within a single molecule, as defined by QuickGO.
What genes are involved in intramolecular transferase activity?
Genes include PUS7, DKC1, PUS1, MUT, PGM1, and JAK3, among others, which encode enzymes or regulators of this activity.
How is intramolecular transferase activity related to cancer?
PUS7, a pseudouridylate synthase, promotes colon cancer proliferation and invasion via PI3K/AKT/mTOR signaling, highlighting the oncogenic potential of these enzymes.
What diseases are associated with defects in intramolecular transferases?
Diseases include dyskeratosis congenita (DKC1 mutations), methylmalonic acidemia (MUT deficiency), and glycogen storage disease (PGM1 deficiency).
What methods are used to study intramolecular transferase activity?
Common methods include enzymatic assays, Pseudo-seq for RNA modifications, Ribo-seq, mass spectrometry, and CRISPR screens.
Can CRISPR be used to study intramolecular transferase genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function and disease mechanisms.
What is the role of pseudouridylate synthases in RNA modification?
Pseudouridylate synthases isomerize uridine to pseudouridine in RNA, which affects RNA structure, stability, and translation.
How is intramolecular transferase activity regulated?
It can be regulated by post-translational modifications, allosteric effectors, and intramolecular interactions, such as Jak3 Y820 phosphorylation.
What are the synonyms for intramolecular transferase activity?
Synonyms include mutase activity and intramolecular transferase activity, transferring other groups.
Why is intramolecular transferase activity important for metabolism?
It enables rearrangements in metabolic pathways, such as in methylmalonyl-CoA mutase and phosphoglucomutase, which are critical for energy homeostasis.
Conclusion
Intramolecular transferase activity (GO:0016866) is a fundamental enzymatic function that drives molecular rearrangements essential for metabolism, RNA modification, and cellular signaling. Its dysregulation is implicated in cancer, ribosomopathies, and metabolic disorders, making it a compelling target for research and therapeutic development. Advances in CRISPR-based models and high-throughput sequencing continue to illuminate the roles of these enzymes, offering new opportunities for drug discovery and precision medicine.
References
- 1. Du J et al.. 2022. Pseudouridylate Synthase 7 Promotes Cell Proliferation and Invasion in Colon Cancer Through Activating PI3K/AKT/mTOR Signaling Pathway.. Dig Dis Sci 67(4):1260-1270 PMID: 33811565
- 2. Bialik S et al.. 2014. The DAP-kinase interactome.. Apoptosis 19(2):316-28 PMID: 24220855
- 4. Kozarich JW. 1988. S-adenosylmethionine-dependent enzyme activation.. Biofactors 1(2):123-8 PMID: 3076439
- 5. Kiss T et al.. 2010. Box H/ACA small ribonucleoproteins.. Mol Cell 37(5):597-606 PMID: 20227365
- 6. Krutyhołowa R et al.. 2019. Charging the code - tRNA modification complexes.. Curr Opin Struct Biol 55:138-146 PMID: 31102979
- 7. Sekine Y et al.. 2022. A novel intramolecular negative regulation of mouse Jak3 activity by tyrosine 820.. Int Immunol 34(6):303-312 PMID: 35192696
- 8. Frey PA. 2001. Radical mechanisms of enzymatic catalysis.. Annu Rev Biochem 70:121-48 PMID: 11395404
